When and How Should we be Measuring Adherence to Antiretroviral Therapy in Resource-Limited Settings?
Journal Title: Journal of Clinical Research in HIV AIDS and Prevention - Year 2013, Vol 1, Issue 2
Abstract
No Abstract
Authors and Affiliations
Denise Evans, Matthew P Fox
Keywords
Related Articles
- EP ID EP262738
- DOI 10.14302/issn.2324-7339.jcrhap-13-edt.1.2
- Views 117
- Downloads 0
Evaluation of Direct Cost of Adverse Drug Reactions to Highly Active Antiretroviral Therapy in Indian Human Immunodeficiency Virus Positive Patients
In India, interruptions to highly active antiretroviral therapy (HAART) are due to adverse drug reactions (ADRs) and no reports on the direct cost incurred in the management of ADRs to HAART are available. There is a nee...
When and How Should we be Measuring Adherence to Antiretroviral Therapy in Resource-Limited Settings?
No Abstract
Single Nucleotide Polymorphisms Associated with Alimentary Fatty Liver Disease are not Genetic Risk Factors for Treatment-associated Hepatic Steatosis in HIV Patients on HAART
No Abstract
Psychosocial Characterization of HIV Clients with Potential to be Change Agents for HIV Prevention in Uganda
New research suggests that people living with HIV have the potential to be strong advocates for HIV prevention by passing on HIV prevention messages within their social networks. However, there is a paucity of research i...
Comment on the Stages of HIV Care Continuum: Considering Treatment for Secondary Prevention among Patients ‘Retained in Care’
No Abstract